Ignite Creation Date:
2025-12-24 @ 11:20 PM
Ignite Modification Date:
2026-01-02 @ 8:43 PM
Study NCT ID:
NCT07011056
Status:
RECRUITING
Last Update Posted:
2025-09-19
First Post:
2025-05-30
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Phase III Clinical Study of Purinostat Mesylate for Injection in Patients With Diffuse Large B-cell Lymphoma
Sponsor:
Chengdu Zenitar Biomedical Technology Co., Ltd
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
ZLPM-001-2.0
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None